Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07735442) titled 'BRIDGE-SIC Efficacy Trial' on July 24.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Single Group Assignment. Primary purpose: Other. Masking: None (Open Label).

Primary Sponsor: Dana-Farber Cancer Institute

Condition: Cancer

Intervention: Behavioral: LLM-generated SIC summary email to clinical teams

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: July 31, 2026

Target Sample Size: 600

Countries of Recruitment: United States

To know more, visit https://clinicaltrials.gov/study/NCT07735442

Disclaimer: Curated by HT Syndication....